COVID-19 levels fall in UK as health officials review variant found in India

By: |
May 13, 2021 3:24 PM

The variant B.1.617.2 is one of three subtypes of the mutation first detected in India and was designated as a VOC by Public Health England (PHE), with over 800 cases being traced in parts of the country.

The European Medicines Agency has said that it is "pretty confident" that vaccines currently in use are effective against the variant B.1.617.2, which remains the view of scientists in the UK at this stage.The European Medicines Agency has said that it is "pretty confident" that vaccines currently in use are effective against the variant B.1.617.2, which remains the view of scientists in the UK at this stage.

The number of people infected with the coronavirus in England fell by almost half over the past month marking the lowest level of COVID-19 cases since last year, according to new statistics released in London on Thursday.

The Imperial College London led Real-time Assessment of Community Transmission (REACT-1) study comes as it emerged that the government’s Scientific Advisory Group for Emergencies (SAGE) is due to hold a review meeting on Thursday to discuss the Variant of Concern (VOC) first identified in India, which UK Prime Minister Boris Johnson told Parliament was of increasing concern as it may be “considerably more transmissible” than the dominant variant in the UK first detected in the county of Kent last year.

The variant B.1.617.2 is one of three subtypes of the mutation first detected in India and was designated as a VOC by Public Health England (PHE), with over 800 cases being traced in parts of the country.

“The scientists on SAGE will make their assessments, they will report back to the government and we will make decisions based on the data and the evidence that they provide, said James Cleverly, UK Foreign Office minister.
It is feared that the June 21 date set in the UK government’s complete lockdown easing roadmap may be impacted from the SAGE analysis.

The European Medicines Agency has said that it is “pretty confident” that vaccines currently in use are effective against the variant B.1.617.2, which remains the view of scientists in the UK at this stage.

Meanwhile, the REACT-1 study, based on over 127,000 home swab tests taken between April 15 and May 3, shows that 0.1 per cent of the population is currently infected, or one in 1,000.

This compares with the study’s previous testing round when 0.2 per cent or one in 500 had the coronavirus as of March 30. The researchers report that since January, the link between the rate of infections, hospitalisations and deaths has become decoupled, with infections associated with fewer hospitalisations and deaths which likely reflects the impact of the vaccination programme.

It is very encouraging that infections have continued to fall while rules have been relaxed in England, and it’s likely that the vaccine rollout has played a key part in helping keep the virus at bay, said Professor Paul Elliott, director of the REACT programme from Imperial’s School of Public Health.

“We need to continue to monitor trends in the coming weeks as restrictions are eased further, and in the meantime, we must continue to stick to the rules to help keep infections down and enable the vaccination programme to continue to protect people, he said.

The study also analysed the genetic code of a small number of positive swab samples to look for variants and while the majority were found to be the so-called Kent variant, the VOC from India was also found in London based on analysis of samples taken for routine testing.

Professor Steven Riley, Professor of Infectious Disease Dynamics at Imperial, said: The fact that our study detected the Indian variant among a small number of samples could be cause for concern.

At the moment it’s unclear whether this variant is more transmissible than B.1.1.7 but this is a risk, so it will be important to closely monitor infections and hospitalisations in areas where this virus is present so that public health responses can be implemented if needed.

The REACT-1 study, carried out by Imperial College London in partnership with Ipsos MORI is tracking current coronavirus infections in the community by testing more than 125,000 randomly-selected people each month over roughly a two-week period. The study recruits new people each month to help ensure the sample represents the wider population and offers a high-resolution snapshot of the situation across a particular time period.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Tamil Nadu lockdown update: Bus, Metro Rail services to resume in Chennai; TN govt eases more curbs
2Delhi records 124 new COVID-19 cases, lowest since February 16; positivity rate 0.17 pc
3Haryana extends lockdown till June 28, announces more relaxations